BMJ Best Practice

参考文献

关键文献

Service FJ, McMahon MM, O'Brien PC, et al. Functioning insulinoma - incidence, recurrence and long term survival of patients: a 60 year study. Mayo Clin Proc. 1991;66:711-719.

Cryer PE. Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol. 1993;264:E149-E155.

Murad MH, Coto-Yglesias F, Wang AT, et al. Drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab. 2009;94:741-745.

Service FJ. Hypoglycemic disorders. N Engl J Med. 1995;332:1144-1152.

参考文章

1.  Khan AI, Vasquez Y, Gray J, et al. The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med. 2006;130:1527-1532.

2.  Whipple AO. The surgical therapy of hyperinsulinoma. J Int Chir. 1938;3:237.

3.  Service FJ, McMahon MM, O'Brien PC, et al. Functioning insulinoma - incidence, recurrence and long term survival of patients: a 60 year study. Mayo Clin Proc. 1991;66:711-719.

4.  Karachaliou R, Vlachopapadopoulou E, Kaldrymidis P, et al. Malignant insulinoma in childhood. J Pediatr Endocrinol Metab. 2006;19:757-760.

5.  Joanna Briggs Institute. Management of asymptomatic hypoglycaemia in neonates. Nurs Stand. 2007;22:35-38.

6.  Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353:249-254.

7.  Palardy J, Havrankova J, Lepage R, et al. Blood glucose measurements during symptomatic episodes in patients with suspected postprandial hypoglycemia. N Engl J Med. 1989;321:1421-1425.

8.  Huopio H, Shyng SL, Otonkoski T, et al. K(ATP) channels and insulin secretion disorders. Am J Physiol Endocrinol Metab. 2002;283:E207-E216.

9.  Cryer PE. Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol. 1993;264:E149-E155.

10.  O'Keefe SJ, Marks V. Lunchtime gin and tonic as a cause of reactive hypoglycemia. Lancet. 1977;1:1286-1288.

11.  Felig P, Brown WV, Levine RA, et al. Glucose homeostasis in viral hepatitis. N Engl J Med. 1970;283:1436-1440.

12.  Garber AJ, Bier DM, Cryer PE, et al. Hypoglycemia in compensated chronic renal insufficiency: substrate limitation of gluconeogenesis. Diabetes. 1974;23:982-986.

13.  Kogut MD, Blaskovics M, Donnell GN, et al. Idiopathic hypoglycemia: a study of twenty-six children. J Pediatr. 1969;74:853-871.

14.  Zimmerman BR. Hypoglycemia from hepatic, renal, and endocrine disorders. In: Service FJ, ed. Hypoglycemic disorders: pathogenesis, diagnosis, and treatment. Boston, MA: GK Hall; 1983.

15.  Merimee TJ, Felig P, Marliss E, et al. Glucose and lipid homeostasis in the absence of human growth hormone. J Clin Invest. 1971;50:574-582.

16.  Miller SI, Wallace RJ Jr, Musher DM, et al. Hypoglycemia as a manifestation of sepsis. Am J Med. 1980;68:649-654.

17.  Talente GM, Coleman RA, Alter C, et al. Glycogen storage disease in adults. Ann Intern Med. 1994;120:218-226.

18.  Rich LM, Caine MR, Findling JW, et al. Hypoglycemic coma in anorexia nervosa: case report and review of the literature. Arch Intern Med. 1990;150:894-895.

19.  Fischer KF, Lees JA, Newman JH, et al. Hypoglycemia in hospitalized patients: causes and outcomes. N Engl J Med. 1996;315:1245-1250.

20.  Service FJ. Factitial hypoglycemia. Endocrinologist. 1992;2:173-176.

21.  Bressler R, Corredor C, Brendel K. Hypoglycin and hypoglycin-like compounds. Pharmacol Rev. 1969;21:105-130.

22.  Kojak G Jr, Barry MJ Jr, Gastineau CF. Severe hypoglycemic reaction with haloperidol: report or a case. Am J Psychiatry. 1969;126:573-579.

23.  Limburg PJ, Katz H, Grant CS, et al. Quinine-induced hypoglycemia. Ann Intern Med. 1993;119:218-219.

24.  Nelson RL. Drug-induced hypoglycemias. In: Service FJ, ed. Hypoglycemic disorders: pathogenesis, diagnosis, and treatment. Boston, MA: G.K. Hall; 1983:97-109.

25.  Murad MH, Coto-Yglesias F, Wang AT, et al. Drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab. 2009;94:741-745.

26.  Fournier JP, Azoulay L, Yin H, et al. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. JAMA Intern Med. 2015;175:186-193.

27.  American Diabetes Association. Consensus statement on self-monitoring of blood glucose. Diabetes Care. 1987;10:95-99.

28.  Service FJ, Natt N. The prolonged fast. J Clin Endocrinol Metab. 2000;85:3973-3974.

29.  Service FJ. Hypoglycemic disorders. N Engl J Med. 1995;332:1144-1152.

30.  DeWitt CR, Heard K, Waksman JC. Insulin & C-peptide levels in sulfonylurea-induced hypoglycemia: a systematic review. J Med Toxicol. 2007;3:107-118.

31.  Marks V, Samols E. Glucagon test for insulinoma: a chemical study in 25 cases. J Clin Pathol. 1968;21:346-352.

32.  Hizuka N, Fukuda I, Takano K, et al. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia. Endocr J. 1998;45(Suppl):S61-S65.

33.  Fedorak IJ, Ko TC, Gordon D, et al. Localization of islet cell tumors of the pancreas: a review of current techniques. Surgery. 1993;113:242-249.

34.  Rosch T, Lightdale CJ, Botet JF, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 1992;326:1721-1726.

35.  Kim CH, Park JH, Park TS, et al. Autoimmune hypoglycemia in a type 2 diabetic patient with anti-insulin and insulin receptor antibodies. Diabetes Care. 2004;27:288-289.

36.  Stephen AE, Hodin RA. Neuroendocrine tumors of the pancreas, excluding gastrinoma. Surg Oncol Clin North Am. 2006;15:497-510.

37.  Hirshberg B, Cochran C, Skarulis MC, et al. Malignant insulinoma: spectrum of unusual clinical features. Cancer. 2005;104:264-272.

38.  Hofeldt FD, Dippe SE, Levin SR, et al. Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma. Diabetes. 1974;23:192-198.

39.  Ricci S, Antonuzzo A, Galli L, et al. Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors. Am J Clin Oncol. 2000;23:412-415.

40.  Kabadi UM, Kabadi MU. Idiopathic reactive hypoglycemia: resolution on increased protein intake secondary to decreased insulin response with enhanced glucagon rise. Endocrine Society Annual Meeting, page 540, abstract no. P2-568. Chevy Chase, MD: Endocrine Society; 2006.

41.  Ahmadpour S, Kabadi UM. Pancreatic alpha-cell function in idiopathic reactive hypoglycemia. Metabolism. 1997;46:639-643.

42.  Khan M, Kabadi UM. Postprandial hypoglycemia. In: Rigobelo EC, ed. Diabetes - damages and treatments. Rijeka, Croatia: InTech Open; 2011:117-126.

43.  Sørensen M, Johansen OE. Idiopathic reactive hypoglycaemia - prevalence and effect of fibre on glucose excursions. Scand J Clin Lab Invest. 2010;70:385-391.

44.  Tsuro K, Kojima H, Okamoto S, et al. Glucocorticoid therapy ameliorated hypoglycemia in insulin-like growth factor-II-producing solitary fibrous tumor. Intern Med. 2006;45:525-529.

使用此内容应接受我们的免责声明